Profiles

Keywords
Last Name
Institution

Connection

Search Results to Nancy Reau

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Reau, Nancy

Item TypeName
Concept Hepatitis C, Chronic
Academic Article Long-term outcomes after treatment with interferon and ribavirin in HCV patients.
Academic Article Evaluation of early null response to pegylated interferon and ribavirin as a predictor of therapeutic nonresponse in patients undergoing treatment for chronic hepatitis C.
Academic Article Naives, nonresponders, relapsers: who is there left to treat?
Academic Article Sticker shock and the price of new therapies for hepatitis C: is it worth it?
Academic Article Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosis.
Academic Article Evaluation of Hepatitis C Patients in the Direct-Acting Antiviral Era.
Academic Article HCV Council--critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape.
Academic Article Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.
Academic Article Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing Agents.
Academic Article Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials.
Academic Article Characterization of nonrapid virologic response patients infected with HCV genotype 1 who may relapse after standard therapy with peginterferon plus ribavirin.
Academic Article Hepatitis C: management of side effects in the era of direct-acting antivirals.
Academic Article Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial.
Academic Article Updates on hepatitis C virus therapy in the direct-acting antiviral era.
Academic Article Patient engagement and study design of PROP UP: A multi-site patient-centered prospective observational study of patients undergoing hepatitis C treatment.
Academic Article Resistance analysis in patients with genotype 1-6 HCV infection treated with sofosbuvir/velpatasvir in the phase III studies.
Academic Article Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy.
Academic Article Hepatitis C Virus Infection Care Pathway-A Report From the American Gastroenterological Association Institute HCV Care Pathway Work Group.
Academic Article Potential consequences of healthcare recommendations: a focus on the U.S. Preventive Services Task Force.
Academic Article Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection.
Academic Article A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study.
Academic Article Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: The PROP UP study.

Search Criteria
  • Hepatitis C Chronic